The Chemours Company (NYSE:CC – Free Report) – Zacks Research reduced their Q2 2025 earnings per share estimates for shares of Chemours in a report released on Wednesday, July 9th. Zacks Research analyst R. Department now anticipates that the specialty chemicals company will earn $0.40 per share for the quarter, down from their previous estimate of $0.47. The consensus estimate for Chemours’ current full-year earnings is $2.03 per share. Zacks R…